financetom
Business
financetom
/
Business
/
Twilio Stock Slides On Mixed Q4 Earnings
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Twilio Stock Slides On Mixed Q4 Earnings
Feb 13, 2025 2:14 PM

Twilio Inc ( TWLO ) reported fourth-quarter financial results after the market close on Thursday. Here’s a look at the key details from the quarter.

Q4 Revenue: $1.19 billion, versus estimates of $1.183 billion

Q4 EPS: $1.00, versus estimates of $1.04

Fourth-quarter revenue was up 11% year-over-year, Communications revenue came in at $1.12 billion, up 12% year-over-year, and Segment revenue totaled $74.1 million, down 1% year-over-year.

Twilio ( TWLO ) had more than 325,000 active customer accounts as of Dec. 31, up from 305,000 at the end of 2023.

Twilio ( TWLO ) generated $108.4 million in operating cash flow and $93.5 million in free cash flow during the fourth quarter. The company ended the quarter with $421.3 million in cash and cash equivalents.

“Twilio’s focus on financial discipline, operational rigor, and innovation is paying off as we delivered a second consecutive quarter of double digit growth and our first ever quarter of GAAP operating profitability,” said Khozema Shipchandler, CEO of Twilio ( TWLO ). “I’m energized by the momentum in our business as we deliver on our vision to ensure every digital interaction between businesses and consumers is amazing.”

See Also: Coinbase Q4 Earnings Highlights: Trading Platform Welcomes ‘Dawn Of A New Era For Crypto’

Outlook: Twilio ( TWLO ) expects first-quarter revenue to be between $1.13 billion and $1.14 billion versus estimates of $1.143 billion, per Benzinga Pro. The company anticipates first-quarter adjusted earnings of 88 cents to 93 cents per share versus estimates of 99 cents per share.

Twilio ( TWLO ) expects full-year 2025 organic revenue growth of 7% to 8%. The company expects to generate $825 million to $850 million in free cash flow in 2025.

Twilio ( TWLO ) said it completed its previous share repurchase program before the end of 2024. The company authorized a new buyback of up to $2 billion in January with an expiration of Dec. 31, 2027.

Twilio ( TWLO ) executives will discuss the quarter on a conference call with investors scheduled for 5 p.m. ET.

Price Action: Twilio ( TWLO ) shares were down 5.37% after hours, trading at $139.37 at the time of publication Thursday, according to Benzinga Pro.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Aptose Biosciences Links With National Cancer Institute to Develop Tuspetinib in MyeloMATCH Trials
Aptose Biosciences Links With National Cancer Institute to Develop Tuspetinib in MyeloMATCH Trials
Dec 3, 2024
07:59 AM EST, 12/03/2024 (MT Newswires) -- Aptose Biosciences ( APTO ) , a precision oncology company, on Tuesday said it has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI). The NCI and Aptose will collaborate on developing Aptose's compound tuspetinib (TUS), an inhibitor of key signaling kinases involved in certain malignancies, in...
Canada's Scotiabank misses profit estimates on higher taxes, expenses
Canada's Scotiabank misses profit estimates on higher taxes, expenses
Dec 3, 2024
(Reuters) - Bank of Nova Scotia missed analysts' estimates for quarterly profit on Tuesday, hurt by higher taxes and elevated expenses related to compensation and technology. Adjusted profit rose 29% to C$2.12 billion ($1.51 billion). On a per share basis, the lender earned C$1.57, compared with analysts' expectations of C$1.60 per share, according to LSEG data. The quarter included impairment...
Merck Say Lung Cancer Treatment Receives FDA Breakthrough Therapy Designation
Merck Say Lung Cancer Treatment Receives FDA Breakthrough Therapy Designation
Dec 3, 2024
07:55 AM EST, 12/03/2024 (MT Newswires) -- Merck ( MRK ) said Tuesday the US Food and Drug Administration has granted breakthrough therapy designation to sacituzumab tirumotecan, a treatment for certain times of non-small cell lung cancer. The designation is based on data from the phase 2 expansion group of a phase 1/2 study, as well as data from two...
Update: AT&T Targets $40 Billion Shareholder Return in 2025 to 2027
Update: AT&T Targets $40 Billion Shareholder Return in 2025 to 2027
Dec 3, 2024
07:56 AM EST, 12/03/2024 (MT Newswires) -- (Updates with additional details from the fifth paragraph.) AT&T ( T ) said Tuesday that it expects more than $50 billion of free cash flow over the next three years and will return at least $40 billion to shareholders through dividends and buybacks. The company said it plans to maintain its current annualized...
Copyright 2023-2026 - www.financetom.com All Rights Reserved